Berkeley 4/29/2010 7:00:00 PM
News / Business

Basal Cell Carcinoma Treatment Options Reviewed by Leading Dermatologists

Basal cell carcinoma (BCC) is the most common form of skin cancer with more than one million cases diagnosed each year. A person diagnosed with basal cell carcinoma faces a number of treatment options, including curettage and electrodessication, cryosurgery, Mohs surgery laser surgery, and topical medications, such as 5-FU and imiquimod. 

Now leading dermatologists offer their expert opinion regarding basal cell carcinoma treatment options.

Dermatologist Lisa Benest, M.D. of the Skincare and Laser Center in Los Angeles, California stated that “larger skin cancers and difficult to treat areas, such as the nose and other areas of the face, would be the likeliest candidates for Mohs surgery. Smaller skin cancers can usually be removed by simple excision or C&D (curettage and dessication)." 

Dr. Benest added that "The major advance in treating BCCs is the use of topical immune system booster, imiquimod have had very good success with many skin cancers using this cream. The advantage is that surgery is avoided, including surgical scars.  The disadvantage is that the cream does create a strong immune reaction, which means the area typically gets very red and scabby for a couple of months.” 

Dermatologist Todd Minars, M.D. of Minars Dermatology in Hollywood, Florida wrote, "There are a few criteria that we use when deciding who is appropriate for Mohs Surgery. This technique is usually used to treat high-risk or difficult basal cell carcinoma or squamous cell carcinoma. A few reasons for referring a patient for Mohs Surgery: location of tumor - if the tumor is in a location that makes it difficult to excise, for example on the nose (where there is very little tissue to work with) or on the face near an important structure like an eye." 

As Dr. Lisa Benest pointed out “Ultimately, each patient should discuss with his or her doctor which treatment option is best for the type, size, and location of the skin cancer." 

The clinical perspective of these leading dermatologists are published online on Vivacare’s “From Your Doctor” patient education service.